BIOLASE, INC Quarterly Debt-to-equity in % from Q1 2012 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Biolase, Inc quarterly Debt-to-equity history and growth rate from Q1 2012 to Q3 2024.
  • Biolase, Inc Debt-to-equity for the quarter ending September 30, 2024 was -1.13K %, a 270% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -1.13K -1.79K -270% Sep 30, 2024
Q2 2024 -2.15K -2.53K -662% Jun 30, 2024
Q1 2024 2.77K +2.52K +974% Mar 31, 2024
Q4 2023 889 +690 +347% Dec 31, 2023
Q3 2023 661 +516 +356% Sep 30, 2023
Q2 2023 383 +263 +220% Jun 30, 2023
Q1 2023 258 +152 +144% Mar 31, 2023
Q4 2022 199 +104 +109% Dec 31, 2022
Q3 2022 145 +35.8 +32.7% Sep 30, 2022
Q2 2022 120 -9.33 -7.22% Jun 30, 2022
Q1 2022 106 -90.9 -46.2% Mar 31, 2022
Q4 2021 95 -451 -82.6% Dec 31, 2021
Q3 2021 109 -897 -89.1% Sep 30, 2021
Q2 2021 129 +2.69K Jun 30, 2021
Q1 2021 197 +6.55K Mar 31, 2021
Q4 2020 546 -567 -50.9% Dec 31, 2020
Q3 2020 1.01K +467 +86.6% Sep 30, 2020
Q2 2020 -2.57K -2.83K -1073% Jun 30, 2020
Q1 2020 -6.35K -6.51K -4080% Mar 31, 2020
Q4 2019 1.11K +1.01K +965% Dec 31, 2019
Q3 2019 539 +471 +687% Sep 30, 2019
Q2 2019 264 +200 +317% Jun 30, 2019
Q1 2019 160 +97.7 +158% Mar 31, 2019
Q4 2018 105 +34.9 +50% Dec 31, 2018
Q3 2018 68.6 -14 -16.9% Sep 30, 2018
Q2 2018 63.3 -17.4 -21.6% Jun 30, 2018
Q1 2018 61.9 -24.9 -28.7% Mar 31, 2018
Q4 2017 69.7 -11.9 -14.6% Dec 31, 2017
Q3 2017 82.5 +6.31 +8.28% Sep 30, 2017
Q2 2017 80.7 +2.28 +2.91% Jun 30, 2017
Q1 2017 86.8 +14.4 +19.9% Mar 31, 2017
Q4 2016 81.6 +17.9 +28.2% Dec 31, 2016
Q3 2016 76.2 +20.6 +37% Sep 30, 2016
Q2 2016 78.4 +17.4 +28.6% Jun 30, 2016
Q1 2016 72.4 -10.5 -12.6% Mar 31, 2016
Q4 2015 63.6 -58.3 -47.8% Dec 31, 2015
Q3 2015 55.7 -213 -79.3% Sep 30, 2015
Q2 2015 61 -237 -79.5% Jun 30, 2015
Q1 2015 82.9 -173 -67.6% Mar 31, 2015
Q4 2014 122 -132 -52.1% Dec 31, 2014
Q3 2014 268 +41.8 +18.4% Sep 30, 2014
Q2 2014 298 +88.3 +42.1% Jun 30, 2014
Q1 2014 256 +73.8 +40.6% Mar 31, 2014
Q4 2013 254 +92.3 +57% Dec 31, 2013
Q3 2013 227 +74 +48.4% Sep 30, 2013
Q2 2013 210 +76.1 +57% Jun 30, 2013
Q1 2013 182 +63.9 +54.1% Mar 31, 2013
Q4 2012 162 Dec 31, 2012
Q3 2012 153 Sep 30, 2012
Q2 2012 134 Jun 30, 2012
Q1 2012 118 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.